In conclusion, our results collectively provided a potential biomarker dataset for NSCLC prognosis and revealed that CALR and PDIA3 were over-expressed in NSCLC compared with adjacent non-tumor lung tissues. The gene discussed is PDIA3; the disease is non-small cell lung carcinoma.